Business Segments Neuronetics, Inc.
Equities
STIM
US64131A1051
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.130 USD | -3.18% |
|
+12.11% | +54.35% |
| Nov. 04 | Neuronetics, Inc., Q3 2025 Earnings Call, Nov 04, 2025 | |
| Nov. 04 | Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | |||||||||
Surgical & Medical Equipment | 49.24M | 55.31M | 65.21M | 71.35M | 74.89M | ||||
Total Assets | 78.66M | 141M | 117M | 116M | 141M | ||||
Interest Expense | -4.52M | -4.02M | -4.25M | -5.42M | -7.29M | ||||
CAPEX | -730K | -2.35M | -3.27M | -2.37M | -1.47M | ||||
EBT | -27.45M | -31.19M | -37.16M | -30.19M | -43.71M | ||||
Gross Profit | 37.69M | 43.66M | 49.72M | 51.7M | 54.16M | ||||
D&A | 941K | 1.06M | 1.65M | 2.01M | 2.07M | ||||
Operating Income | -22.31M | -27.56M | -35.11M | -30.55M | -34.56M | ||||
Net Income | -27.45M | -31.19M | -37.16M | -30.19M | -43.71M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
United States | 47.52M | 53.45M | 63.41M | 69.34M | 72.49M | ||||
International | 1.72M | 1.86M | 1.8M | 2.01M | 2.4M |
- Stock Market
- Equities
- STIM Stock
- Financials Neuronetics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
